Trial | NCT00004422  Report issue

Title

Intravenous Pertussis Immune Globulin in Patients With Severe Childhood Pertussis Infection

  • Phase

    Phase 3

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Study Participants

    174
OBJECTIVES:

Assess the efficacy of a single infusion of a high titer pertussis immune globulin for the treatment of severe pertussis in children.
PROTOCOL OUTLINE: This is a randomized, multicenter study. Patients are randomized to receive an infusion of either pertussis immune globulin or placebo (0.9% saline).

Patients are followed every 2 weeks for up to 6 months.

Completion date provided represents the completion date of the grant per OOPD records
Study Started
Aug 31
1997
Study Completion
Sep 30
2002
Last Update
Mar 25
2015
Estimate

Drug immune globulin

Criteria 

Documented infection with Bordetella pertussis
No Results Posted